AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Working Capital to Net Assets Ratio
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Working Capital to Net Assets ratio of 680.4% as of December 2025. Working capital of €-294.15 Million (current assets of €134.40 Million minus current liabilities of €428.55 Million) is measured against net assets of €-43.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See AEST.MED.INT.HLD.SP.ADR/3 balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
AEST.MED.INT.HLD.SP.ADR/3 Working Capital to Net Assets (2021–2025)
This chart shows how AEST.MED.INT.HLD.SP.ADR/3's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 680.4%, reflecting working capital of €-294.15 Million against net assets of €-43.23 Million EUR. Check AEST.MED.INT.HLD.SP.ADR/3 tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for AEST.MED.INT.HLD.SP.ADR/3 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of AEST.MED.INT.HLD.SP.ADR/3.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 680.4% | €-294.15 Million | €-43.23 Million | €134.40 Million | €428.55 Million | ▲ +4039.6 pp |
| 2024 | -3359.3% | €-313.96 Million | €9.35 Million | €88.08 Million | €402.04 Million | ▼ -2467.7 pp |
| 2023 | -891.5% | €-299.81 Million | €33.63 Million | €111.57 Million | €411.38 Million | ▼ -1261.9 pp |
| 2022 | 370.4% | €-466.24 Million | €-125.88 Million | €77.60 Million | €543.84 Million | ▲ +140.8 pp |
| 2021 | 229.6% | €-427.95 Million | €-186.42 Million | €113.71 Million | €541.66 Million | — |